NR3C1 and neoplasm: In addition, the glucocorticoid receptor (GR) agonist dexamethasone reversibly arrested the cell cycle of tumour cells, with increased expression of the glucocorticoid receptor in the G1 phase, and following the withdrawal of dexamethasone, the cells slowly resumed the cycle [59].